We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

214 hedge funds and large institutions have $1.42B invested in TG Therapeutics in 2023 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $41.9M | Put options by funds: $21.1M

50% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 36

28% more capital invested

Capital invested by funds: $1.11B → $1.42B (+$315M)

8% more funds holding

Funds holding: 198 → 214 (+16)

0.59% more ownership

Funds ownership: 64.24% → 64.83% (+0.59%)

2% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 62

Holders
214
Holders Change
+16
Holders Change %
+8.08%
% of All Funds
3.41%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
54
Increased
61
Reduced
62
Closed
36
Calls
$41.9M
Puts
$21.1M
Net Calls
+$20.8M
Net Calls Change
-$6.1M

Top Buyers

Rank Fund Capital Flow
1
DGM
Darwin Global Management
Jersey
+$159M
2
JFG
Jefferies Financial Group
New York
+$77.5M
3
GTC
Ghost Tree Capital
New York
+$16.7M
4
SSA
Schonfeld Strategic Advisors
New York
+$15.2M
5
DCM
Driehaus Capital Management
Illinois
+$12.9M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$54.2M
2
MC
Maverick Capital
Texas
-$51.1M
3
State Street
State Street
Massachusetts
-$42.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$32.3M
5
WP
Woodline Partners
California
-$30.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIS
201
Sound Income Strategies
Florida
$3.01K +$3.04K +200 New
UB
202
UMB Bank
Missouri
$2.96K – – –
Federated Hermes
203
Federated Hermes
Pennsylvania
$2.84K -$6.01K -396 -68%
Commonwealth Equity Services
204
Commonwealth Equity Services
Massachusetts
$2.33K +$198K +13,007 +9%
QC
205
Quent Capital
New York
$2.08K +$1.67K +110 +393%
PCA
206
Providence Capital Advisors
North Carolina
$1.91K – – –
BAAM
207
Baker Avenue Asset Management
California
$1.4K – – –
BIA
208
Bell Investment Advisors
California
$1.31K – – –
FHA
209
First Horizon Advisors
Tennessee
$1.08K +$1.09K +72 New
CAL
210
Capital Advisors Ltd
Ohio
$1K – – –
IAIM
211
International Assets Investment Management
Florida
$196 +$197 +13 New
Northwestern Mutual Wealth Management
212
Northwestern Mutual Wealth Management
Wisconsin
$75 +$76 +5 New
MC
213
Maverick Capital
Texas
– -$51.1M -4,318,700 Closed
WP
214
Woodline Partners
California
– -$30.3M -2,562,100 Closed
PVI
215
Pura Vida Investments
New York
– -$5.97M -504,829 Closed
TI
216
Trexquant Investment
Connecticut
– -$4.57M -386,467 Closed
TLP
217
Tri Locum Partners
New York
– -$3.41M -288,462 Closed
Qube Research & Technologies (QRT)
218
Qube Research & Technologies (QRT)
United Kingdom
– -$2.55M -215,527 Closed
IHAM
219
Integral Health Asset Management
New York
– -$1.77M -150,000 Closed
CM
220
Capula Management
Cayman Islands
– -$1.59M -134,060 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
221
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$1.58M -133,600 Closed
E
222
Ergoteles
New York
– -$1.5M -126,383 Closed
EGI
223
EAM Global Investors
California
– -$1.29M -108,820 Closed
MAP
224
Moody Aldrich Partners
Massachusetts
– -$1.23M -103,925 Closed
Renaissance Technologies
225
Renaissance Technologies
New York
– -$1.17M -99,100 Closed
6 7 8
9
10

TGTX Hedge Fund Activity: Q1 2023 in Review

214 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q1 2023, worth a combined $1.42B — up 28% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new TGTX positions and 36 closed out — a net gain of 18 holders — while 61 added to existing stakes and 62 trimmed.

The largest buyer was Darwin Global Management, opening a new position worth an estimated $159M. The largest seller was Millennium Management, cutting an estimated $54.2M.

  • 214 institutional investors held TG Therapeutics (TGTX) as of Q1 2023, up from 198 in Q4 2022.
  • Funds reported $1.42B of TG Therapeutics stock for Q1 2023, up 28% quarter-over-quarter.
  • 54 funds opened new TG Therapeutics positions in Q1 2023 and 36 closed out, a net change of +18 holders.
  • The largest TG Therapeutics buyer in Q1 2023 was Darwin Global Management, an estimated $159M added.
  • The largest TG Therapeutics seller in Q1 2023 was Millennium Management, an estimated $54.2M sold.

Based on aggregated 13F filings for Q1 2023.